Korlym and Symbicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Korlym (mifepristone) and Symbicort (budesonide; formoterol fumarate dihydrate). Common drug interactions include headache among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Korlym and Symbicort. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,792 Symbicort users. Check the latest studies of Symbicort.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

54 people who take Korlym and Symbicort together, and have interactions are studied.

What are the common drug interactions of Korlym and Symbicort, by gender? *:

female:

Headache (pain in head)
Back pain
Peripheral swelling
Weight increased
Blood pressure increased
Asthenia (weakness)
Arthralgia (joint pain)
Decreased appetite
Diarrhoea
Dyspnoea (difficult or laboured respiration)

male:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Lung cancer metastatic (lung cancer spreads to other parts)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Korlym and Symbicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood glucose decreased
Fatigue (feeling of tiredness)
Abdominal discomfort
Asthenia (weakness)
Blood potassium decreased
Blood pressure decreased
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Glycosylated haemoglobin increased
Anxiety

50-59:

Blood glucose increased
Bone pain
Pain in extremity
Peripheral swelling
Abdominal discomfort
Arthralgia (joint pain)
Asthenia (weakness)
Blood potassium increased
Blood pressure increased
Depression

60+:

Nausea (feeling of having an urge to vomit)
Back pain
Depressed mood
Hypoaesthesia (reduced sense of touch or sensation)
Insomnia (sleeplessness)
Peripheral swelling
Blood pressure increased
Headache (pain in head)
Blood glucose decreased
Abnormal behaviour

What are the existing conditions these people have? *

Cushing's Syndrome (obesity, a rounded face, increased fat): 51 people, 94.44%

* Approximation only. Some reports may have incomplete information.

Do you take Korlym and Symbicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously